+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Atrial Fibrillation Market By Type, By Technology, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • PDF Icon

    Report

  • 180 Pages
  • March 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640542
Description Jump to:
The atrial fibrillation market size was valued at $1,825.8 million in 2020, and is projected to reach $3,370.7 million by 2030, registering a CAGR of 6.4% from 2021 to 2030. Atrioventricular fibrillation (AFib) is a disorder, in which the heart's upper chambers (atria) beat quickly and erratically (fibrillate). Blood can accumulate and clot in the left atrial appendage of the heart as a result of AFib. A stroke can occur when a blood-clot escapes from the left atrial appendage (LAA) and transfers to another parts or organs of the body. Atrial fibrillation can increase the risk of heart stroke, induce chest discomfort, or even trigger a heart attack, especially if the heart beat is extremely rapid, and can produce blood clots in the heart that spread to other organs.

The global atrial fibrillation market is expanding along with the increase in the ageing population. In addition, high blood pressure, obesity, and diabetes result in the increase in occurrence of atrial fibrillation in the geriatric population. According to the Centers for Disease Control and Prevention (CDC) estimates of the prevalence of AFib in the U.S. ranges from about 2.7 million to 6.1 million. That number is estimated to rise to 12.1 million in 2030. Such factors are expected to increase the demand for atrial fibrillation devices during the forecast period. Furthermore, technical advancements in surgical devices for atrial fibrillation propel the atrial fibrillation market forward. However, problems such as expensive atrial fibrillation treatment costs and costly medical devices are expected to hamper the market expansion.

Moreover, technological advancements force key players to introduce atrial fibrillation monitoring and devices in the medical and pharmaceutical sectors. For instance, in February 2020, Janssen Pharmaceutical Companies of Johnson & Johnson collaborated with Apple Inc. and introduced Heartline Monitor. It improves health outcomes, such as lowering the risk of stroke, by detecting atrial fibrillation (AFib) earlier.

The market is segmented on the basis of type, technology, end user and geography. On the basis of type, it is divided into surgical and non-surgical. On the basis of technology, it is divided into radiofrequency, laser, cryotherapy, and others. On the basis of end user, the market is segmented into hospitals, specialty clinics, and others. Region-wise, the market analysis is conducted across North America (the U.S., Canada, and Mexico), Europe (the UK, France, Germany, Italy, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

The key players operating in the global atrial fibrillation market are Abbott Laboratories, Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, Medtronic plc, Biotronik SE & Co. KG, Philips N.V., Siemens AG, AtriCure Inc., and CardioFocus, Inc.

Key Benefits For Stakeholders

  • The report provides an extensive analysis of the current and emerging atrial fibrillation market trends and dynamics.
  • In-depth atrial fibrillation market analysis is conducted by constructing market estimations for key Market Segment between 2021 and 2030.
  • Extensive analysis of the atrial fibrillation market is conducted by following key product positioning and monitoring of top competitors within the market framework.
  • A comprehensive analysis of all the regions is provided to determine the prevailing opportunities.
  • The global atrial fibrillation market forecast analysis from 2021 to 2030 is included in the report.
  • The key players within atrial fibrillation market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the atrial fibrillation industry.

    Key Market Segments


BY TYPE

  • Surgical
  • Non-Surgical

BY TECHNOLOGY

  • Radiofrequency
  • Laser
  • Cryotherapy
  • Others

BY END USER

  • Hospitals
  • Specialty Clinics
  • Others

BY REGION

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East
  • Africa

Key Market Players

  • Johnson & Johnson
  • MicroPort Scientific Corporation
  • Boston Scientific Corporation
  • st. jude medical
  • Medtronic plc
  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Koninklijke Philips N.V.
  • Siemens AG
  • AtriCure Inc

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: ATRIAL FIBRILLATION MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Surgical
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Non-Surgical
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: ATRIAL FIBRILLATION MARKET, BY TECHNOLOGY
5.1 Overview
5.1.1 Market size and forecast
5.2 Radiofrequency
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Laser
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Cryotherapy
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Others
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: ATRIAL FIBRILLATION MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Specialty Clinics
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: ATRIAL FIBRILLATION MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Technology
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Technology
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Technology
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Technology
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Technology
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Technology
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Technology
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 U.K.
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Technology
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Technology
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Rest of Europe
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Technology
7.3.5.5.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Technology
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Technology
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 India
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Technology
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 Japan
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Technology
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 South Korea
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Technology
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 Rest of Asia-Pacific
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Technology
7.4.5.5.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Technology
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Latin America
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Technology
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Middle East
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Technology
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Technology
7.5.5.3.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Johnson & Johnson
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 MicroPort Scientific Corporation
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Boston Scientific Corporation
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 st. jude medical
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Medtronic plc
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Abbott Laboratories
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Biotronik SE & Co. KG
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Koninklijke Philips N.V.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Siemens AG
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 AtriCure Inc
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global Atrial Fibrillation Market, by Type, 2020-2030, ($Million)
Table 2. Atrial Fibrillation Market Revenue, for Surgical, by Region, 2020-2030, ($Million)
Table 3. Atrial Fibrillation Market Surgical by Country, 2020-2030, ($Million)
Table 4. Atrial Fibrillation Market Revenue, for Non-Surgical, by Region, 2020-2030, ($Million)
Table 5. Atrial Fibrillation Market Non-Surgical by Country, 2020-2030, ($Million)
Table 6. Global Atrial Fibrillation Market, by Technology, 2020-2030, ($Million)
Table 7. Atrial Fibrillation Market Revenue, for Radiofrequency, by Region, 2020-2030, ($Million)
Table 8. Atrial Fibrillation Market Radiofrequency by Country, 2020-2030, ($Million)
Table 9. Atrial Fibrillation Market Revenue, for Laser, by Region, 2020-2030, ($Million)
Table 10. Atrial Fibrillation Market Laser by Country, 2020-2030, ($Million)
Table 11. Atrial Fibrillation Market Revenue, for Cryotherapy, by Region, 2020-2030, ($Million)
Table 12. Atrial Fibrillation Market Cryotherapy by Country, 2020-2030, ($Million)
Table 13. Atrial Fibrillation Market Revenue, for Others, by Region, 2020-2030, ($Million)
Table 14. Atrial Fibrillation Market Others by Country, 2020-2030, ($Million)
Table 15. Global Atrial Fibrillation Market, by End-user, 2020-2030, ($Million)
Table 16. Atrial Fibrillation Market Revenue, for Hospitals, by Region, 2020-2030, ($Million)
Table 17. Atrial Fibrillation Market Hospitals by Country, 2020-2030, ($Million)
Table 18. Atrial Fibrillation Market Revenue, for Specialty Clinics, by Region, 2020-2030, ($Million)
Table 19. Atrial Fibrillation Market Specialty Clinics by Country, 2020-2030, ($Million)
Table 20. Atrial Fibrillation Market Revenue, for Others, by Region, 2020-2030, ($Million)
Table 21. Atrial Fibrillation Market Others by Country, 2020-2030, ($Million)
Table 22. Atrial Fibrillation Market, by Region, 2020-2030, ($Million)
Table 23. North America Atrial Fibrillation Market, by Type, 2020-2030, ($Million)
Table 24. North America Atrial Fibrillation Market, by Technology, 2020-2030, ($Million)
Table 25. North America Atrial Fibrillation Market, by End-user, 2020-2030, ($Million)
Table 26. North America Atrial Fibrillation Market, by Country, 2020-2030, ($Million)
Table 27. U.S. Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 28. U.S. Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 29. U.S. Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 30. Canada Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 31. Canada Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 32. Canada Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 33. Mexico Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 34. Mexico Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 35. Mexico Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 36. Europe Atrial Fibrillation Market, by Type, 2020-2030, ($Million)
Table 37. Europe Atrial Fibrillation Market, by Technology, 2020-2030, ($Million)
Table 38. Europe Atrial Fibrillation Market, by End-user, 2020-2030, ($Million)
Table 39. Europe Atrial Fibrillation Market, by Country, 2020-2030, ($Million)
Table 40. Germany Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 41. Germany Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 42. Germany Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 43. France Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 44. France Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 45. France Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 46. U.K. Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 47. U.K. Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 48. U.K. Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 49. Italy Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 50. Italy Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 51. Italy Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 52. Rest of Europe Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 53. Rest of Europe Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 54. Rest of Europe Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 55. Asia-Pacific Atrial Fibrillation Market, by Type, 2020-2030, ($Million)
Table 56. Asia-Pacific Atrial Fibrillation Market, by Technology, 2020-2030, ($Million)
Table 57. Asia-Pacific Atrial Fibrillation Market, by End-user, 2020-2030, ($Million)
Table 58. Asia-Pacific Atrial Fibrillation Market, by Country, 2020-2030, ($Million)
Table 59. China Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 60. China Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 61. China Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 62. India Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 63. India Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 64. India Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 65. Japan Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 66. Japan Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 67. Japan Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 68. South Korea Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 69. South Korea Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 70. South Korea Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 71. Rest of Asia-Pacific Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 72. Rest of Asia-Pacific Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 73. Rest of Asia-Pacific Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 74. LAMEA Atrial Fibrillation Market, by Type, 2020-2030, ($Million)
Table 75. LAMEA Atrial Fibrillation Market, by Technology, 2020-2030, ($Million)
Table 76. LAMEA Atrial Fibrillation Market, by End-user, 2020-2030, ($Million)
Table 77. LAMEA Atrial Fibrillation Market, by Country, 2020-2030, ($Million)
Table 78. Latin America Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 79. Latin America Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 80. Latin America Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 81. Middle East Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 82. Middle East Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 83. Middle East Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 84. Africa Atrial Fibrillation Market by Type 2020-2030, ($Million)
Table 85. Africa Atrial Fibrillation Market by Technology 2020-2030, ($Million)
Table 86. Africa Atrial Fibrillation Market by End-user 2020-2030, ($Million)
Table 87. Johnson & Johnson: Company Snapshot
Table 88. Johnson & Johnson: Operating Segments
Table 89. Johnson & Johnson: Product Portfolio
Table 90. Johnson & Johnson: Net Sales
Table 91. Johnson & Johnson: Key Stratergies
Table 92. Microport Scientific Corporation: Company Snapshot
Table 93. Microport Scientific Corporation: Operating Segments
Table 94. Microport Scientific Corporation: Product Portfolio
Table 95. Microport Scientific Corporation: Net Sales
Table 96. Microport Scientific Corporation: Key Stratergies
Table 97. Boston Scientific Corporation: Company Snapshot
Table 98. Boston Scientific Corporation: Operating Segments
Table 99. Boston Scientific Corporation: Product Portfolio
Table 100. Boston Scientific Corporation: Net Sales
Table 101. Boston Scientific Corporation: Key Stratergies
Table 102. St. Jude Medical: Company Snapshot
Table 103. St. Jude Medical: Operating Segments
Table 104. St. Jude Medical: Product Portfolio
Table 105. St. Jude Medical: Net Sales
Table 106. St. Jude Medical: Key Stratergies
Table 107. Medtronic plc: Company Snapshot
Table 108. Medtronic plc: Operating Segments
Table 109. Medtronic plc: Product Portfolio
Table 110. Medtronic plc: Net Sales
Table 111. Medtronic plc: Key Stratergies
Table 112. Abbott Laboratories: Company Snapshot
Table 113. Abbott Laboratories: Operating Segments
Table 114. Abbott Laboratories: Product Portfolio
Table 115. Abbott Laboratories: Net Sales
Table 116. Abbott Laboratories: Key Stratergies
Table 117. Biotronik Se & Co. Kg: Company Snapshot
Table 118. Biotronik Se & Co. Kg: Operating Segments
Table 119. Biotronik Se & Co. Kg: Product Portfolio
Table 120. Biotronik Se & Co. Kg: Net Sales
Table 121. Biotronik Se & Co. Kg: Key Stratergies
Table 122. Koninklijke Philips N.V.: Company Snapshot
Table 123. Koninklijke Philips N.V.: Operating Segments
Table 124. Koninklijke Philips N.V.: Product Portfolio
Table 125. Koninklijke Philips N.V.: Net Sales
Table 126. Koninklijke Philips N.V.: Key Stratergies
Table 127. Siemens Ag: Company Snapshot
Table 128. Siemens Ag: Operating Segments
Table 129. Siemens Ag: Product Portfolio
Table 130. Siemens Ag: Net Sales
Table 131. Siemens Ag: Key Stratergies
Table 132. Atricure Inc: Company Snapshot
Table 133. Atricure Inc: Operating Segments
Table 134. Atricure Inc: Product Portfolio
Table 135. Atricure Inc: Net Sales
Table 136. Atricure Inc: Key Stratergies
LIST OF FIGURES
Figure 1. Atrial Fibrillation Market Segmentation
Figure 2. Atrial Fibrillation Market, 2020-2030
Figure 3. Atrial Fibrillation Market, 2020-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Atrial Fibrillation Market:Drivers, Restraints and Opportunities
Figure 11. Atrial Fibrillation Market, by Type, 2020 (%)
Figure 12. Comparative Share Analysis of Surgical Atrial Fibrillation Market, 2020-2030 (%)
Figure 13. Comparative Share Analysis of Non-Surgical Atrial Fibrillation Market, 2020-2030 (%)
Figure 14. Atrial Fibrillation Market, by Technology, 2020 (%)
Figure 15. Comparative Share Analysis of Radiofrequency Atrial Fibrillation Market, 2020-2030 (%)
Figure 16. Comparative Share Analysis of Laser Atrial Fibrillation Market, 2020-2030 (%)
Figure 17. Comparative Share Analysis of Cryotherapy Atrial Fibrillation Market, 2020-2030 (%)
Figure 18. Comparative Share Analysis of Others Atrial Fibrillation Market, 2020-2030 (%)
Figure 19. Atrial Fibrillation Market, by End-user, 2020 (%)
Figure 20. Comparative Share Analysis of Hospitals Atrial Fibrillation Market, 2020-2030 (%)
Figure 21. Comparative Share Analysis of Specialty Clinics Atrial Fibrillation Market, 2020-2030 (%)
Figure 22. Comparative Share Analysis of Others Atrial Fibrillation Market, 2020-2030 (%)
Figure 23. Atrial Fibrillation Market by Region, 2020
Figure 24. U.S. Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 25. Canada Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 26. Mexico Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 27. Germany Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 28. France Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 29. U.K. Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 30. Italy Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 31. Rest of Europe Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 32. China Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 33. India Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 34. Japan Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 35. South Korea Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 36. Rest of Asia-Pacific Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 37. Latin America Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 38. Middle East Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 39. Africa Atrial Fibrillation Market, 2020-2030 ($Million)
Figure 40. Top Winning Strategies, by Year
Figure 41. Top Winning Strategies, by Development
Figure 42. Top Winning Strategies, by Company
Figure 43. Product Mapping of Top 10 Players
Figure 44. Competitive Dashboard
Figure 45. Competitive Heatmap of Top 10 Key Players
Figure 46. Johnson & Johnson.: Net Sales, ($Million)
Figure 47. Microport Scientific Corporation.: Net Sales, ($Million)
Figure 48. Boston Scientific Corporation.: Net Sales, ($Million)
Figure 49. St. Jude Medical.: Net Sales, ($Million)
Figure 50. Medtronic PLC.: Net Sales, ($Million)
Figure 51. Abbott Laboratories.: Net Sales, ($Million)
Figure 52. Biotronik SE & Co. KG.: Net Sales, ($Million)
Figure 53. Koninklijke Philips N.V. Net Sales, ($Million)
Figure 54. Siemens AG.: Net Sales, ($Million)
Figure 55. Atricure Inc.: Net Sales, ($Million)

Executive Summary

According to this report titled, 'Atrial Fibrillation Market,' the atrial fibrillation market size was valued at $1,825.85 million in 2020, and is estimated to reach $3.4 Billion by 2030, growing at a CAGR of 6.4% from 2021 to 2030.

Atrial fibrillation is a type of irregular heartbeat characterized by rapid and irregular beating. Blood may clot and congest in the atria at the same time because of insufficient blood received by ventricles. These clots can enter the circulation and reach the brain, causing stroke. The transmission of electrical impulses to the lower heart chambers is disrupted in atrial fibrillation, which causes a rapid, slow, or irregular heartbeat. During atrial fibrillation, upper chamber and lower chamber of the heart beat irregularly, chaotically, and out of sync, which causes shortness of breath, chest pain, weakness, ad lightheadedness or fainting.

Numerous technical improvements in the treatment and diagnostics of atrial fibrillation, as well as the rise in prevalence of atrial fibrillation in the senior population, are major drivers of atrial fibrillation industry. However, market expansion is hampered by problems, such as strict government laws, expensive treatment costs for atrial fibrillation, and shortage of experienced specialists and technicians.

Key players focus on expanding their portfolio by introducing technologically developed products, which re expected to help reduce the risk of stroke and atrial fibrillation in patients. For instance, in April 2021, ArtiCure, Inc., a major pioneer in atrial fibrillation (Afib) therapy introduced Epi-Sense System, which is approved by the U.S. Food & Drug Administration (FDA). Epi-Sense System is used to treat patients with long-standing persistent cardiac arrhythmias or atrial fibrillation.

However, during the COVID-19 pandemic lockdown, various manufacturers in the atrial fibrillation market had to stop their business in countries, such as China, the U.S., and India, which negatively affected the atrial fibrillation market growth. This break directly impacted the sales and decline in atrial fibrillation market share. In addition, lack of manpower and raw materials also constricted supply of equipment of atrial fibrillation, which negatively influenced the growth of the market. However, reopening of production facilities and introduction of vaccines for COVID-19 are anticipated to lead to re-opening of atrial fibrillation companies.

Key findings of the Study

  • The report provides an extensive analysis of the current and emerging atrial fibrillation market trends and dynamics.
  • Depending on type, the surgical segment dominated the atrial fibrillation market, in terms of revenue in 2020 and is projected to grow at a significant CAGR during the forecast period.
  • By technology, the radiofrequency segment registered highest revenue in 2020.
  • By end user the hospitals segment registered highest revenue in 2020.
  • Asia-Pacific is projected to register highest growth rate in the coming years.
  • The report provides atrial fibrillation market forecast analysis from 2021 to 2030.
  • Depending on type, the surgical segment dominated the atrial fibrillation market, in terms of revenue in 2020 and is projected to grow at a significant CAGR during the forecast period.
The key players within the atrial fibrillation market are profiled in this report, and their strategies are analyzed thoroughly, which help understand competitive outlook of the atrial fibrillation industry.

The report provides an extensive analysis of the current trends and emerging opportunities of the atrial fibrillation market size.

In-depth atrial fibrillation market analysis is conducted by constructing estimations for the key segments between 2021 and 2030.

The atrial fibrillation market share analysis from 2020 to 2030 is included in the report.

In-depth analysis of atrial fibrillation market size is conducted by constructing market estimations for regions and countries between 2020 and 2030.

The report includes atrial fibrillation market opportunity and comprehensive analysis of all the regions is provided to determine the prevailing opportunities.

Companies Mentioned

  • Johnson & Johnson
  • MicroPort Scientific Corporation
  • Boston Scientific Corporation
  • st. jude medical
  • Medtronic plc
  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Koninklijke Philips N.V.
  • Siemens AG
  • AtriCure Inc

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMarch 2022
Forecast Period2020 - 2030
Estimated Market Value ( USD ) in 2020 $ 1825.8 million
Forecasted Market Value ( USD ) by 2030 $ 3370.7 million
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Atrial Fibrillation Global Market Report 2024 - Product Image

Atrial Fibrillation Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Atrial Fibrillation Treatment Market Report by Disorder Type, Treatment Type, End-User, and Region 2024-2032 - Product Image

Atrial Fibrillation Treatment Market Report by Disorder Type, Treatment Type, End-User, and Region 2024-2032

  • Report
  • 142 Pages
  • Global
From
Atrial Fibrillation Diagnostics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Atrial Fibrillation Diagnostics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 90 Pages
  • Global
From
2024 Global Forecast for Atrial Fibrillation Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Atrial Fibrillation Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Atrial Fibrillation Surgery Market by Product, Indication, End-User - Global Forecast 2025-2030 - Product Image

Atrial Fibrillation Surgery Market by Product, Indication, End-User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.